If validated, the discovery by St Jude scientists could offer real tools to deal with hyperinflammatory immune responses, one of the leading causes of death in Covid-19 infections

Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

A new survey finds 52 percent of individuals feel their symptoms are “ignored, dismissed, or not believed” when seeking medical treatment. That number rises to 6-in-10 within the Hispanic community.

As the federal government prepares to launch the national three-digit number “988” for the mental health crisis hotline next month, a new KFF analysis shows that suicide death rates increased by 12 percent in the decade from 2010 to 2020 — with death rates rising the fastest among people of color, younger individuals, and people who live in rural areas.